Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
428.88B
Market cap428.88B
Price-Earnings ratio
19.09
Price-Earnings ratio19.09
Dividend yield
2.85%
Dividend yield2.85%
Average volume
7.50M
Average volume7.50M
High today
$178.80
High today$178.80
Low today
$176.72
Low today$176.72
Open price
$177.34
Open price$177.34
Volume
7.16M
Volume7.16M
52 Week high
$181.16
52 Week high$181.16
52 Week low
$140.68
52 Week low$140.68

JNJ News

Benzinga 19h
Jim Cramer Says Johnson & Johnson Stock Could Power Through $200 Next

Despite ongoing legal battles related to its talc products, Johnson & Johnson JNJ stock has climbed over 23% year-to-date. CNBC’s Jim Cramer on Thursday attrib...

Jim Cramer Says Johnson & Johnson Stock Could Power Through $200 Next
Benzinga 3d
Johnson & Johnson's FDA-Approved Bladder Cancer Drug Offers New Option For Patients Avoiding Surgery

On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson's JNJ Inlexzo (gemcitabine intravesical system) as a new treatment approach f...

Johnson & Johnson's FDA-Approved Bladder Cancer Drug Offers New Option For Patients Avoiding Surgery
Benzinga 3d
Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst

Johnson & Johnson JNJ on Tuesday won regulatory approval for its drug delivery product Inlexzo to treat high-risk non-muscle invasive bladder cancer, a mileston...

Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst

Analyst ratings

58%

of 26 ratings
Buy
42.3%
Hold
57.7%
Sell
0%

More JNJ News

Seeking Alpha 3d
Johnson & Johnson gains approval of gemcitabine for local delivery into bladder

Healthcare Johnson & Johnson gains approval of gemcitabine for local delivery into bladder Sep. 09, 2025 5:07 PM ET Johnson & Johnson (JNJ) Stock By: Jonathan B...

Johnson & Johnson gains approval of gemcitabine for local delivery into bladder
TipRanks 4d
Johnson & Johnson announces FDA approval of INLEXZO

Johnson & Johnson announced the U.S. FDA approved INLEXZO, a new, potentially practice-changing approach for treating patients with certain types of bladder can...

TipRanks 4d
Johnson & Johnson Elects John Morikis to Board

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Seeking Alpha 4d
Johnson & Johnson appoints former Sherwin-Williams CEO to its board of directors

Johnson & Johnson appoints former Sherwin-Williams CEO to its board of directors Sep. 09, 2025 4:07 AM ET Johnson & Johnson (JNJ) Stock, JNJ:CA Stock By: Meghav...

Johnson & Johnson appoints former Sherwin-Williams CEO to its board of directors
TipRanks 4d
J&J names former Sherwin-Williams CEO to board

Johnson & Johnson (JNJ) announced that John Morikis, retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company (SHW), has been ele...

TipRanks 7d
Nvidia, J&J, JPMorgan, McDonald’s, Roku: Major Stock Sales Unveiled

Insiders have been trading these 5 stocks: ((NVDA)), ((JNJ)), ((JPM)), ((MCD)) and ((ROKU)). Here is a breakdown of their recent trades and their value. Elevate...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.